NTPIF News and Press, Nam Tai Property Inc.

Nam Tai Property Inc. (OTC Expert Market: NTPIF) (the “Company”) is pleased to announce a significant milestone in its Technology Center project. The Company’s subsidiary, Nam Tai Investment, has successfully entered into a six-year master lease agreement with a high-profil...

2025-06-09 18:03:20 ET Christensen Capital, LLC manages a hedge fund called Target 3 Fund, LP. Target 3 Fund, LP has a 25-year history of excess returns with low risk. We write very few articles because good investment ideas are very rare. Previous articles: 2019 St. Joe (JOE), up 167%,...

2025-05-23 07:37:57 ET Summary In late 2024, Nam Tai Property regained full control of its mainland China assets and agreed to settle virtually all outstanding litigation. In recent months, the company has regained access to local bank financing, retained a new audit firm and bols...

2025-04-30 09:30:00 ET Summary ENDI Corp's shares rose significantly, driven by a substantial increase in AUM and a value-unlocking transaction, suggesting further upside potential. Finch Therapeutics awaits a post-trial decision that could significantly impact its share value, wi...

2025-04-25 06:30:00 ET Summary Arquitos returned 13.8% net of fees in Q1 2025 and is up an estimated 30% year-to-date despite market turmoil. I am highly confident in our top four positions, which are uncorrelated to general markets and have strong company-specific catalysts. ...

2025-04-07 08:51:43 ET More on Nam Tai Property Financial information for Nam Tai Property Read the full article on Seeking Alpha For further details see: Nam Tai Property to sell Wuxi Property for RMB 224.8M

2025-02-05 07:10:00 ET Summary Arquitos Fund achieved a 29.6% return in 2024, outperforming the S&P 500's 25.0% return, driven by strategic investments in key positions. Finch Therapeutics, a 7% portfolio holding, won a significant patent case, potentially leading to enhanced ...